Privacy-aware multi-institutional time-to-event studies

Author:

Späth JulianORCID,Matschinske Julian,Kamanu Frederick K.,Murphy Sabina A.,Zolotareva Olga,Bakhtiari Mohammad,Antman Elliott M.,Loscalzo Joseph,Brauneck Alissa,Schmalhorst Louisa,Buchholtz Gabriele,Baumbach Jan

Abstract

Clinical time-to-event studies are dependent on large sample sizes, often not available at a single institution. However, this is countered by the fact that, particularly in the medical field, individual institutions are often legally unable to share their data, as medical data is subject to strong privacy protection due to its particular sensitivity. But the collection, and especially aggregation into centralized datasets, is also fraught with substantial legal risks and often outright unlawful. Existing solutions using federated learning have already demonstrated considerable potential as an alternative for central data collection. Unfortunately, current approaches are incomplete or not easily applicable in clinical studies owing to the complexity of federated infrastructures. This work presents privacy-aware and federated implementations of the most used time-to-event algorithms (survival curve, cumulative hazard rate, log-rank test, and Cox proportional hazards model) in clinical trials, based on a hybrid approach of federated learning, additive secret sharing, and differential privacy. On several benchmark datasets, we show that all algorithms produce highly similar, or in some cases, even identical results compared to traditional centralized time-to-event algorithms. Furthermore, we were able to reproduce the results of a previous clinical time-to-event study in various federated scenarios. All algorithms are accessible through the intuitive web-app Partea (https://partea.zbh.uni-hamburg.de), offering a graphical user interface for clinicians and non-computational researchers without programming knowledge. Partea removes the high infrastructural hurdles derived from existing federated learning approaches and removes the complexity of execution. Therefore, it is an easy-to-use alternative to central data collection, reducing bureaucratic efforts but also the legal risks associated with the processing of personal data to a minimum.

Funder

H2020 Health

Publisher

Public Library of Science (PLoS)

Reference49 articles.

1. Survival analysis in clinical trials: Basics and must know areas;R Singh;Perspect Clin Res,2011

2. Censoring in clinical trials: review of survival analysis techniques.;S Prinja;Indian J Community Med,2010

3. Compassionate use of remdesivir for patients with severe Covid-19;J Grein;N Engl J Med,2020

4. Long-term trends in the incidence of and survival with heart failure;D Levy;N Engl J Med,2002

5. Breast cancer survival prediction using seven prognostic biomarker genes;L Liu;Oncol Lett,2019

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. OASIS portable: user-friendly offline suite for secure survival analysis;Molecules and Cells;2024-01

2. Private Continuous Survival Analysis with Distributed Multi-Site Data;2023 IEEE International Conference on Big Data (BigData);2023-12-15

3. Federated statistical analysis: non-parametric testing and quantile estimation;Frontiers in Applied Mathematics and Statistics;2023-11-13

4. The FeatureCloud Platform for Federated Learning in Biomedicine: Unified Approach;Journal of Medical Internet Research;2023-07-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3